Financement
Organisateur: ASOCIACION ESPAÑOLA CONTRA EL CANCER
50 financements 8 928 219,00 €
2025
-
Tamáriz, Luis - AECC Clínico Junior 2025
154 000,00 €
2024
-
Neoadjuvant-adjuvant immunotherapy and cancer vaccines to improve survival in hepatocellular carcinoma
600 000,00 €
-
Small cell lung cancer: from biology networks to tailored therapy - Small cell lung cancer (SOSCLC)
45 500,00 €
-
Rational to modulate the Microbiome-induced Endoplasmic Reticulum stress as tool to avoid the immune evasion in Hepatocellular Carcinoma (RETO)
42 162,00 €
-
Estudio de los mecanismos de resistencia y de infección en paciente con mieloma en recaída y refractario en tratamiento con anticuerpos biespecíficos.
240 000,00 €
-
¿CARACTERIZACIÓN DE LA HETEROGENEIDAD MOLECULAR Y TRANSCRIPCIONAL DE LOS LINFOMAS DEL CENTRO GERMINAL: LINFOMA DE CÉLULAS GRANDES B Y LINFOMA FOLICULAR¿
140 000,00 €
-
Epigenetic landscape of immune resistance in pancreatic cancer
54 705,00 €
-
Small cell lung cancer: from biology networks to tailored therapy - Small cell lung cancer (SOSCLC)
35 000,00 €
2023
-
Rational to modulate the Microbiome and the Microbiome-induced Endoplasmic Reticulum stress as tool to avoid the immune evasion in Hepatocellular Carcinoma (RETO)
309 592,00 €
-
First-in-human, open-label, prospective, non-randomized clinical trial to evaluate the safety of ARI-HER2 (HER2BBz CAR-T cells) in subjects with relapse or refractory HER2-positive metastatic breast cancer.
22 000,00 €
-
AECC POSTD235059RUIZ
125 000,00 €
-
Profundización en la vía del Enpp1: efectos autónomos e implicaciones para la radioterapia del cáncer de mama triple negativo
240 000,00 €
-
Hijacking stroma antigens for CAR-T cell immunotherapy of PDAC
100 000,00 €
-
Boosting abscopal effect and minimizing locoregional failure by blockade of IL6/STAT3/SMG1 axis in
onco-radiotherapy
150 000,00 €
-
Hijacking stroma antigens for CAR-T cell immunotherapy of PDAC
110 000,00 €
-
Epigenetic landscape of immune resistance in pancreatic cancer.
300 000,00 €
-
PREDOC AECC 2023 ENEKO GARATE
21 815,00 €
-
Integrated Identification of Risk and Screening in Lung Cancer
10 000,00 €
-
AECC INVES234938VALE
150 000,00 €